Ti02-free coating platform for EU tablet producers

Published: 9-Feb-2022 Featured companies: JRS Pharma
Manufacturing Ingredients

Vivacoat free has been launched to help manufacturers formulate products without titanium dioxide

Vivacoat free is a titanium dioxide-free ready-to-use tablet coating from JRS Pharma.

Following an investigation by the European Food Safety Authority, titanium dioxide has been deemed "not safe" for use as a food additive, and will be banned in the EU in 2022, with regulations expected to follow in other regions. Vivacoat free can be used to replace coatings containing Ti02, with custom options for both white and dark tablet cores.

The coating is designed to offer high opacity across the colour spectrum, and is suitable for both pharmaceutical and nutraceutical products.

Featured companies

JRS Pharma is a leading manufacturer of excipients, offering a complete portfolio of excipient solutions for the pharmaceutical and nutraceutical industries. Our excipients...
See more

You may also like

Manufacturing

JRS Pharma builds new manufacturing facility in Iowa, USA

Read more
It will add a number of new high-value jobs with positions in operations, maintenance, warehouse, and quality

Trending Articles

  1. Sanofi invests €40m into biopharmaceutical manufacturing at its Lyon Gerland site The pharma giant has expanded its French monoclonal antibody production capabilities, while also dedicating €25m to the development of a second-gen polyclonal antibody
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Pharmaceutics International bolsters its prefilled syringe production capabilities The aseptic and oral dosage CDMO has invested USD $3.6m into advanced labelling, fill/finish and automated visual inspection technologies at its Hunt Valley site in Maryland, US
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Tabletability, compactability and compressibility: What’s the difference? To patients and consumers, tablets are a simple and convenient dosage form, but the science behind compressing a block of particles or granules into a single tablet can be complicated. Here, the tablet experts Natoli explain how to develop tabletability, compactibility, and compressibility profiles

Relevant companies

See more

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

JRS Pharma builds new manufacturing facility in Iowa, USA

It will add a number of new high-value jobs with positions in operations, maintenance, warehouse, and quality
Ingredients

Introducing LUBRITAB RBW (Rice Bran Wax)

The clean label lubricant for tablet and capsule formulations
Manufacturing

Optimise continuous manufacturing using PROSOLV EASYtab

Learn more about PROSOLV EASYtab from JRS Pharma
Manufacturing

Comprehensive analysis into disintegration mechanisms: How reliable are textbook recommendations?

New white paper by Emily Sabath Scientist, Research & Development at JRS Pharma
Ingredients

JRS Pharma taps into Chinese market with cDMF filings for excipients portfolio

Ingredients by the German excipient maker have been included in the Chinese Drug Master File with the National Medical Products Administration
Ingredients

JRS PHARMA expands its product portfolio with the addition of the Povidone Family

JRS PHARMA, a leading manufacturer of excipients has announced the worldwide release of the Povidone Family product line, the latest addition to its portfolio
Ingredients

JRS Pharma to offer povidone products

Strategic alliance expands company's product portfolio
Subscribe now